Showing 1881 - 1900 of 2557 results
The analytical power of non-destructive X-ray fluorescence microscopy (XFM) at the Australian Synchrotron has been highlighted in a book chapter in Giorgione, Dante and the Sydney Incunable that features its use on an historic Renaissance work, Dante’s Commedia.
Research on the impacts of land-use, contamination, water management and climate variability on aquatic ecosystems..
ANSTO environmental scientists have alerted the scientific community of the critical need to monitor changes to ice containing potential nuclear fallout that reached Antarctica from 20th century atmospheric weapons testing.
Research has helped build a record of rainfall during the late Pleistocene and Holocene, and shed light on the strategies of Indigenous Australians to cope with a changing landscape.
Infastructure used on the Energy Materials Project.
Specifications and Instrument references.
Publications and resources from the Powder Diffraction beamline.
Research makes it possible to assess if and how rocky coasts, which make up the majority of the world’s coasts including Australia and New Zealand, will respond to changes in marine conditions.
Researchers led by the University of Bristol (UK) have identified a possible cause of SARS-CoV-2’s increased infectivity compared to SARS-CoV
ANSTO is supporting the introduction of particle therapy, an advanced form of radiation treatment for difficult-to-treat cancers, in Australia
Research to improve knowledge of natural variability in rainfall and recharge by monitoring hydrological processes in key regions and reconstruct water recharge history.
Oportunity to to gain expertise on neutron instruments
You are invited to submit to the various awards from ANSTO and the User Meeting 2024 organising committee.
X-ray crystallography at the Australian Synchrotron contributed to major research findings.
Frequently asked questions on the Mo-99 Manufacturing Facility and the ANSTO Nuclear Medicine project.
A targeted radioactive infusion that is a game-changer in late-stage prostate cancer can also dramatically improve outcomes for patients in earlier stages of this disease, a Peter Mac-led study has shown.